-
Trump says Iran wants deal, US 'armada' larger than in Venezuela raid
-
US Justice Dept releases new batch of documents, images, videos from Epstein files
-
Four memorable showdowns between Alcaraz and Djokovic
-
Russian figure skating prodigy Valieva set for comeback -- but not at Olympics
-
Barcelona midfielder Lopez agrees contract extension
-
Djokovic says 'keep writing me off' after beating Sinner in late-nighter
-
US Justice Dept releasing new batch of Epstein files
-
South Africa and Israel expel envoys in deepening feud
-
French eyewear maker in spotlight after presidential showing
-
Olympic dream 'not over', Vonn says after crash
-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
| RBGPF | 1.65% | 83.78 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| CMSC | 0.02% | 23.7 | $ | |
| BCC | -0.97% | 79.4 | $ | |
| BTI | -0.12% | 60.135 | $ | |
| RELX | -1.69% | 35.565 | $ | |
| NGG | -0.81% | 84.37 | $ | |
| GSK | 1.33% | 51.34 | $ | |
| RIO | -4.86% | 90.725 | $ | |
| JRI | 0.32% | 12.997 | $ | |
| CMSD | -0.12% | 24.03 | $ | |
| BCE | -0.18% | 25.44 | $ | |
| VOD | -0.58% | 14.625 | $ | |
| AZN | 0.75% | 93.285 | $ | |
| BP | -1.1% | 37.625 | $ |
'We're already living in science fiction': The neurotech revolution
From translating thoughts into words to allowing paralysed people to walk, the field of neurotechnology has been quietly surging ahead, raising hopes of medical breakthroughs -- and profound ethical concerns.
Some observers even think that neurotech could end up being as revolutionary as the far more hyped rise of artificial intelligence (AI).
"People do not realise how much we're already living in science fiction," King's College London researcher Anne Vanhoestenberghe told AFP.
The scientist leads a laboratory developing electronic devices which are implanted into a person's nervous system -- not just the brain, but also the spinal cord that transmits signals to the rest of the body.
It has been a big couple of years for neurotech research. In June, Californian scientists revealed that a brain implant they developed could translate the thoughts of a man with the neurodegenerative disease ALS into words almost instantly, in just one-fortieth of a second.
Swiss researchers meanwhile have enabled several paralysed people to regain significant control of their body -- including walking again -- by implanting electrodes into their spinal cords.
These experiments, and other trailblazers in the field, are still far from restoring full capability to patients who have lost the ability to talk or walk.
It also remains to be seen how such technology, some of which requires invasive brain surgery, could be made available to people in need across the world.
But still, "the general public is unaware of what is already out there and changing lives," Vanhoestenberghe said.
And these devices are becoming more effective at a remarkable rate, she emphasised.
"Previously it took thousands of hours of training before someone could compose several words using their thoughts," she said. "Now it only takes a couple."
- Musk wants human-AI 'symbiosis' -
Neurotechnology has been propelled by a combination of scientific advances -- including growing understanding of the human brain -- and technological progress which has shrunk devices down so small they can slot into our skulls.
Algorithms using artificial intelligence have significantly sped things along, helping to interpret and transform the data coming from brains.
Numerous start-ups that have emerged since the late 2000s have raised tens of billions of dollars for research that has only recently started translating into concrete achievements.
The most publicised company is billionaire Elon Musk's Neuralink, which says that it has now implanted 12 people with its chip.
While Musk has made characteristically lofty claims, experts have remained cautious about his firm's accomplishments.
"Neuralink is currently just smoke and mirrors, with a lot of hype," Herve Chneiweiss, a neurologist and expert in ethics at France's research organisation INSERM, told AFP.
However, "the day they manage to produce commercial products -- and it won't be long -- it will be too late to worry about it," he cautioned.
Many experts are concerned about the ethical implications of neurotechnology -- particularly because some companies are looking well beyond healthcare applications, instead hoping to use computers to improve our cognitive abilities.
Musk, for one, has repeatedly said he ultimately wants Neuralink to allow humans to achieve "symbiosis" with AI.
- 'Innermost thoughts under threat' -
Against this background, the United Nations' agency for science and culture UNESCO recently approved recommendations for how nations can regulate neurotechnology.
These recommendations -- which are not legally binding -- are due to come into effect on Wednesday.
The authors, who include Chneiweiss, adopted a broad definition of neurotech. It includes devices already widely available such as smartwatches and headsets that do not directly interact with the brain, but instead measure indicators providing an idea of the user's mental state.
"Today, the main risk is invasion of privacy: our innermost thoughts are under threat," Chneiweiss said.
He warned, for example, that neurotech data could "fall into the hands of your boss", who could then decide that you are not spending enough time thinking about work.
Some have already started trying to address such concerns.
Late last year, the US state of California, a global hub of neurotech research, passed a law protecting the brain data of consumers.
D.Johnson--AT